Saturday, December 10, 2022
HomeIndustriesBiotechnology

Biotechnology

Biomind Labs Announces Design of a Pharmaceutical Form for Psychedelic Drug Delivery Using 3D Printing

Biomind Labs Inc., a leading biotech company in fast-acting psychedelics is pleased to announce the successful design of an oromucosal solid pharmaceutical form obtained...

Brain Navi NaoTrac, the Brain Surgical Navigation Robot, Received European CE Mark Approval in 2021

Brain Navi Biotechnology, a Taiwan-based startup specializing in innovative navigation robots, received CE mark approval for brain surgery procedures in Q1 2021 for its...

Lysogene Secures a €4.3 Million Non-dilutive Financing From Bpifrance to Support Its Development

Lysogene, a phase 3 gene therapy platform Company targeting central nervous system (CNS) diseases, announced that it has secured a €4.3 million non-dilutive financing...

Leronlimab (350 mg) Weekly Use for 14 Weeks in Open Label Arm of NASH Trial Produces Fibrosis Reduction as High as 93 msec Amongst...

CytoDyn Inc., a late-stage biotechnology company developing leronlimab, a CCR5 antagonist with the potential for multiple therapeutic indications, reported data from its trial treating...

Puma Biotechnology Announces U.S Patent Term Extension for NERLYNX® (neratinib)

Puma Biotechnology, Inc. a biopharmaceutical company, announced that the United States Patent and Trademark Office (USPTO) issued a Patent Term Extension Certificate for U.S....
0FansLike
3,602FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics